Researchers looked at the prevalence and effects of whole-genome duplication events across cancers using targeted sequenced data for almost 10,000 advanced cases.

The syndromes — HLRCC and SDH PGL/PCC — suppress DNA repair by homologous recombination, rendering tumors vulnerable to PARP inhibitors. 

Silicon Valley VC firm DFJ led the investment in Verge, which is applying machine learning to the development of new drugs for Parkinson's and ALS.

The plaintiffs claim that Qiagen's QIAseq kits infringe Archer's US Patent No. 10,017,810, which covers parts of its Anchored Multiplex PCR (AMP) technology.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.

Blood is a proven, reliable sample source when it comes to DNA analysis; however, it is time consuming, expensive and an invasive collection for donors. Finding a comparable source of genetic material that is more cost effective and less invasive would be extremely beneficial. Could saliva be the answer?  Read this white paper for an in-depth analysis of DNA quality, sample type functionality/ease-of-use and costs associated with saliva and blood for DNA collection.

For any analysis of the gut microbiota, it is essential to capture an accurate microbiome snapshot of the richness and relative abundance of microbes present at the moment of collection. Each collection and transportation method has the potential to expose samples to conditions incompatible with microbiome stabilization. Failure to properly stabilize the microbiome during sample collection, transport, and processing risk obscuring the biological and clinical meaning of the microbiome profile. 

RNA sequencing is rapidly gaining popularity in research and drug development with distinct advantages over microarrays and other technologies. Considerations for sample preparation, sequencing strategy and bioinformatics are critical for consistent quality data, especially when dealing with challenging FFPE
samples.


Learn how BGI used its extensive NGS experience to optimize complete workflows and QA processes to
obtain the best results.